Investors
Careers
Contact Us
About Us
Our Products
Our Pipeline
Our Technology
Stock
Nasdaq:
DEPO
Price:
3.09 -0.18
Volume:
389,637
20 minute delay
In The News
June 11, 2009
Depomed to Present at Jefferies 3rd Annual Healthcare Conference
June 3, 2009
Depomed to Present at Needham & Company's 8th Annual Life Sciences Conference
June 2, 2009
Depomed Completes Enrollment of Phase 3 Clinical Program of DM-1796 in Post-Herpetic Neuralgia
June 1, 2009
Depomed Names Shay Weisbrich Vice President of Marketing
May 19, 2009
Depomed to Host Investor Day in New York City - RSVP Requested